Brief: Abeona Therapeutics Announces Option Exercise By Beacon Therapeutics For Novel AAV204 Capsid For Ophthalmology Gene Therapy
01/07/2025 12:33
July 1 (Reuters) - Abeona Therapeutics Inc ABEO.O: ABEONA THERAPEUTICS® ANNOUNCES OPTION EXERCISE BY BEACON THERAPEUTICS FOR NOVEL AAV204 CAPSID FOR OPHTHALMOLOGY GENE THERAPY ABEONA THERAPEUTICS INC - TO RECEIVE UNDISCLOSED UPFRONT PAYMENT AND TIERED ROYALTIES ABEONA THERAPEUTICS INC - WORLDWIDE NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN ABEONA AND BEACON Source text: ID:nGNX9RXLQq Further company coverage: ABEO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports